InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion

Sep.19.2025
At InterTabac 2025, Mylor Innovation Lab launched its JuiSour series of sourness solutions, attracting clients across Europe, the Middle East, etc. The JuiSour series enhance aroma and juiciness, and improve sour-sweet balance by reformulating the flavor, customizing the formulation and using a “Golden Sour-Sweet Ratio” model . Mylor emphasizes compliance and foresees two key trends “compliance-driven growth” and “flavor segmentation”, helping partners stand out in a homogenized global market.

2Firsts, September 19, 2025, Dortmund, Germany – On the second day of InterTabac 2025, Mylor Innovation Lab drew attention with the debut of its JuiSour series solution for e-liquids. The booth was crowded with visitors, as clients from the United States, Europe, the Middle East, and Southeast Asia stopped to test the new products.

 

“This release is not just about a new product—it is a systematic reconstruction of how sourness is designed”, Ruby, Product Director of Mylor, told 2Firsts at the booth.

 

InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
Mylor Innovation Lab booth | Source: 2Firsts

 

Leveraging the Global Stage: Multi-Dimensional Innovation

 

According to Ruby, Mylor chose to launch the JuiSour series at InterTabac not only to leverage the exhibition’s global influence in rapidly raising the new product’s visibility, but also to demonstrate the company’s strengthened commitment to its globalization strategy. “This exhibition allows us to strengthen ties with partners and distributors worldwide, laying a foundation for further market expansion”, Ruby said.

 

At this year’s event, Mylor presented two major categories of new products:

 

  • Several new e-liquid formulations tailored to regional taste preferences;

 

  • Its flagship innovation, the JuiSour series, is designed to redefine sourness in e-liquids, offering a more natural and refreshing sour taste while creating a juicy, lush, and deeply immersive sensory experience.

 

InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
Mylor Innovation Lab exhibits | Source: 2Firsts

 

Ruby explained that Mylor’s R&D focuses on three fields:

 

  • Flavor authenticity and differentiation: Not only authentically recreates broad flavor profile such as fruits, desserts, and beverages but also explores unique sensory memories through nuanced taste layers and lasting aftertastes;

 

  • Safety and compliance: Strictly adheres to international standards in raw material selection and formulation;

 

  • Holistic balanced sensory experience: Achieves a refined balance across five key dimensions: aroma, sweetness, cooling sensation, sourness, and nicotine impact (including throat hit, head rush, and chest kick).

 

Groundbreaking the limitation of Acetic Acid: Three Key Innovations

 

Sourness is one of the five basic tastes and plays a critical role in e-liquids by enhancing aroma profile, balancing sweetness, and improving juiciness. However, acetic acid—the most common sour agent—often lead to an unnatural sourness, strong nasal harshness, and sharp throat sting at high concentrations.

 

Positioned as a breakthrough solution, the JuiSour series provide vaping brands with sensory differentiation and technological barriers to help them stand out in a competitive market.

 

“Our goal with JuiSour is to make sourness a powerful tool for innovation rather than a limitation for product development”, Ruby noted.

 

Ruby outlined three key innovations:

 

  • Flavor system reconstruction: Using a scientific framework of “aroma burst – sour-sweet balance – enhanced juiciness” to avoid negative sensations of acetic acid while enhancing aroma complexity and authenticity;

 

  • Targeted matching and customization: JuiSour-Berry enhances the aroma intensity, aroma reproduction and aroma burst; JuiSour-Candy balances sweetness, reduces sweetness linger, and improves freshness and smoothness; JuiSour-Citrus boosts juiciness and natural sourness in citrus and beverage flavors;

 

  • “Golden Sour-Sweet Ratio” model: Mylor pioneers the introduction of the sweet-sour concept from the food and beverages industry into the e-liquid sector, establishing new sensory benchmarks tailored to different flavor profiles.

 

InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
Mylor Innovation Lab booth | Source: 2Firsts

 

Compliance and Differentiation as Core Pillars

 

Mylor’s products are now distributed across Europe, Russia, the Middle East, Southeast Asia, and North America, with expansion underway in South America and Africa.

 

On compliance, the company has adopted a “compliance-first” principle. Its production line is built according to GMP standards with Class 1,000 cleanroom facilities. In June 2025, its laboratory received CNAS accreditation, enabling independent testing and issuance of certified reports. Integrating MES smart manufacturing, the U9 system, SRM supply chain management systems, and WMS warehouse systems, Mylor has built a full traceability framework spanning raw materials, production, and shipment.

 

The company has also passed ISO9001 (Quality Management), ISO14001 (Environmental Management), and ISO45001 (Occupational Health & Safety) certifications. In addition, collaborations with international tobacco firms ensure strict adherence to global standards, driving continuous improvement in product quality and regulatory compliance.

 

InterTabac 2025|Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
Mylor Innovation Lab's Certification Certificate | Source: Mylor Innovation Lab 

 

Looking ahead, Ruby sees two defining trends in the global e-liquid market over the next two to three years:

 

       1.    Compliance-driven growth: Stricter and more detailed regulations, with compliance and transparency as key market thresholds;

 

       2.    Flavor segmentation: Consumer demands across dimensions such as aroma profile, sweetness, cooling sensation, sourness, and nicotine impact will evolve from “broad categories” to greater refinement. Multidimensions of sensory profiles including authentic aroma, precise sweet-sour ratios, multi-layered cooling sensations, juicy and tangy profiles, as well as rapid nicotine headrush and intense throat hit—will become critical factors in brand competition.

 

Forward-Looking Strategy: From Flavor Simulation to Flavor Design

 

Ruby revealed that Mylor has already established a dual-driven R&D system combining sensory science and consumer behavior research, continuously iterating and optimizing its flavor design and sensory profile models.

 

At the same time, the company has made technical reserves in regional flavor specialties (such as Asian tea profiles and tropical fruit extractions) and atmospheric flavors (such as rainforest and oceanic bases). With solutions like JuiSour, Mylor is pushing the industry from “flavor simulation” toward “flavor design”, further reinforcing experiential differentiation.

 

Mylor will continue to empower flavor innovation through sensory science, working with global partners to define the next generation of vaping experiences.

 


For more technical information or collaboration inquiries, please contact: max@Mylorbio.com/+86 13714124978

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
On Nov 12, 2026, the European Parliament adopted a resolution on implementing Europe’s Beating Cancer Plan by 447 votes to 66, with 91 abstentions, urging the European Commission to speed up revisions to the Tobacco Products Directive (TPD) and Tobacco Advertising Directive (TAD). Parliament called for broader regulation of e-cigarettes, heated tobacco, nicotine pouches and other emerging nicotine products, proposing measures on packaging, health warnings, flavors, ingredient reporting, online age verification, digital marketing and premarket health impact assessments. EUNews and others reported that the Commission’s Regulatory Scrutiny Board (RSB) issued a negative opinion on the revisions’ impact assessment on Nov 9. The Commission had scheduled the initiative for December 2026, but the reported setback could push the legislative proposal into 2027. No revised official timetable has been announced, and Parliament’s resolution does not amend existing EU law.
Regulations
Nov.19
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13